The FDA and CDC recommended a pause for Ixchiq, a chikungunya vaccine, following reports of adverse events in recipients 60 ...

A new study published Thursday warns that tiger mosquitoes are increasingly spreading to Europe because of climate change, ...

The U.S. government is advising that international travelers age 60 and older not get a chikungunya vaccine as it ...

The CDC began recommending Ixchiq last year for adults traveling to countries where chikungunya is common. The vaccine uses a ...

TUESDAY, May 13, 2025 (HealthDay News) — U.S. health officials are telling travelers aged 60 and older to avoid a chikungunya ...

The feverish diseases dengue and chikungunya could soon become endemic in Europe as the tiger mosquitoes that transmit these ...

Adults over the age of 60 are recommended not to get the chikungunya vaccine to prevent the mosquito-borne illness due to two ...

The Trump administration's FDA and CDC is advising U.S. patients using the drug Ixchiq to hold off while U.S. health ...

The FDA and CDC are investigating reports of serious adverse events, including deaths, in recipients of Ixchiq.

A vaccine designed to protect against chikungunya, a mosquito-borne illness, has been temporarily paused for individuals aged 60 and older.

With National Dengue Day observed on May 16, Pune officials have given instructions to screen people with symptoms at primary ...